Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Jaspreet S. Brar
JCP
Original Research
Bupropion Sustained Release as a Smoking Cessation Treatment in Remitted Depressed Patients Maintained on Treatment With Selective Serotonin Reuptake Inhibitor Antidepressants
JCP
Letter to the Editor
Dr Chengappa and Colleagues Reply
JCP
Original Research
Effects of Behavioral Therapy on Weight Loss in Overweight and Obese Patients With Schizophrenia or Schizoaffective Disorder
JCP
Original Research
Randomized Placebo-Controlled Adjunctive Study of an Extract of
Withania somnifera
for Cognitive Dysfunction in Bipolar Disorder
JCP
Letter to the Editor
"Reply to Increasing Energy Expenditure Is Important to Enchance Management of Antipsychotic-Associated Weight Gain."
JCP
Original Research
Risperidone Use at a State Hospital: A Clinical Audit 2 Years After the First Wave of Risperidone Prescriptions
JCP
Original Research
Varenicline for Smoking Cessation in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Study
JCP
Original Research
Benefits of Ashwagandha for Schizophrenia
Read a study on how a extract of Ashwagandha (Withania somnifera), when added to antipsychotic medications to patients with schizophrenia.